Ensign Peak Advisors, Inc Bristol Myers Squibb CO Transaction History

Ensign Peak Advisors, Inc

$54.2 Billion
Q2 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 2,257,479 shares of BMY stock, worth $120 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,257,479

Previous 2,299,709 1.84%

Holding current value

$120 Million

Previous $125 Million 24.82%

% of portfolio

0.17%

Previous 0.23%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $1.7 Million - $2.24 Million	-42,230 Reduced 1.84%	2,257,479 $93.8 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $14.9 Million - $16.9 Million	-310,467 Reduced 11.89%	2,299,709 $125 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $43.3 Million - $51.6 Million	-892,343 Reduced 25.48%	2,610,176 $134 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $42.6 Million - $47.6 Million	-735,497 Reduced 17.35%	3,502,519 $203 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $16 Million - $17.8 Million	-251,159 Reduced 5.59%	4,238,016 $271 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $1.74 Million - $1.97 Million	26,450 Added 0.59%	4,489,175 $311 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $6.36 Million - $7.53 Million	92,901 Added 2.13%	4,462,725 $321 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $24,539 - $14.5 Million	-188,768 Reduced 4.14%	4,369,824 $311 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $46.3 Million - $50.9 Million	636,926 Added 16.24%	4,558,592 $351 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $114 Million - $137 Million	1,851,821 Added 89.47%	3,921,666 $286 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $25.4 Million - $29.6 Million	-473,538 Reduced 18.62%	2,069,845 $129 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $1.98 Million - $2.32 Million	-33,428 Reduced 1.3%	2,543,383 $150 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $9.75 Million - $10.6 Million	-157,469 Reduced 5.76%	2,576,811 $172 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $15 Million - $16.9 Million	253,416 Added 10.21%	2,734,280 $173 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $52.2 Million - $59.1 Million	903,931 Added 57.32%	2,480,864 $154 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $28.9 Million - $32 Million	502,967 Added 46.83%	1,576,933 $95.1 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $4.04 Million - $4.73 Million	73,774 Added 7.38%	1,073,966 $63.1 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $6.94 Million - $10.1 Million	-149,469 Reduced 13.0%	1,000,192 $55.8 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $56.6 Million - $73.8 Million	1,149,661 New	1,149,661 $73.8 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Bristol Myers Squibb CO Transaction History